Amanda Kay

[Amanda Kay @AJKay17]

@NiallHarbison Thank you for posting. I have a pet with a condition that means early passing, and I don’t know how to do it. I think you showed me.

[Amanda Kay @AJKay17]

@gvwilson @deepgenomics Amazing!

[Amanda Kay @AJKay17]

@LifeSciVC Unbelievable!

[Amanda Kay @AJKay17]

What do you get when you mix AI, RNA therapeutics, and experts in both? Fun! Check out our series of Deep Dives ... #biotech #AI

[Deep Genomics @deepgenomics]

Welcome to Deep Dive, our new interview series on the potential of applying AI to RNA therapeutics. Our first interview is with our CEO and founder, Brendan Frey, PhD, FRSC, and Tal Zaks, MD, PhD, and member of our Strategic Advisory Board. #AI #deeplearning #futureofmedicine

[Amanda Kay @AJKay17]

@JMaraganore Wow! That's pretty cool!

[Amanda Kay @AJKay17]

Proud of this team, especially today ...

[Deep Genomics @deepgenomics]

Today is International Day of Women and Girls in Science. To commemorate, we're kicking off our #WomeninScience series where you will meet members of our team and learn about why they chose a career in science, and at @deepgenomics. Stay tuned! #AI #biotech #deeplearning #careers

[Amanda Kay @AJKay17]

Congratulations Brendan Frey! Our mission started in Toronto, and only more to come, in Cambridge too! Check out roles on my corp dev team - strategy, BD, financial modeling, or many other disciplines at Deep Genomics: https://t.co/05F6iB343j; #biotechjobs #kendalljobs

[Deep Genomics @deepgenomics]

Thank you @TorontoLife for recognizing our Founder and CEO, @frey_brendan as one of the 50 most influential Torontonians of 2021! Read the article below. #AI #Toronto #TorontoLife #deeplearning #artificialintelligence

[Deep Genomics @deepgenomics]

We are thrilled to announce industry veteran, Tal Zaks, MD, PhD, has joined our Strategic Advisory Board. Read more here: https://t.co/zDGyvidnwg
#AI #deeplearning #drugdevelopment #mRNAtherapeutics

[Amanda Kay @AJKay17]

Lookin' good in lights Deep Genomics!

[Deep Genomics @deepgenomics]

Thank you to @TMXGroup for featuring our name in lights! Read more about our recent news -- $180M Series C financing, the largest in Canadian biotech history https://t.co/75NuB4zM5Z
#ai #artificialintelligence #financing #deeplearning #genomics #TSX #biotech

[Amanda Kay @AJKay17]

Check out Deep Genomics’ Series C news to learn more about what Brendan and the team have built and where we go from here!

#AI #aiinhealthcare #genomics #drugdevelopment #softwareengineerjobs #machinelearningjobs #machinelearning #RNA

[Deep Genomics @deepgenomics]

Today we announced a $180M Series C financing, which will allow us to expand our #AI discovery platform for 'Programmable' RNA therapeutics and support the advancement of our portfolio into the clinic. More here: https://t.co/9enA9krwAG #deeplearning #genomics #financing #biotech

[Amanda Kay @AJKay17]

I dig the new blog the team started...great way to get to see how Deep Genomics applies AI to programming RNA medicines! Check it out...

[Deep Genomics @deepgenomics]

Thrilled to share our inaugural blog post authored by Daniele Merico, Head of Target Identification, and featured on our website. Learn more about our #AI Workbench and our approach to programming RNA therapeutics. https://t.co/I4cqDqLKFq #genomics #deeplearning #biotech

[Amanda Kay @AJKay17]

@synlogic_tx Who won?!?

[Amanda Kay @AJKay17]

Thank you Pfizer team! Just amazing ...

[Pfizer Inc. @pfizer]

📸: The first shipment from our Kalamazoo plant. @UPS @FedEx
.
.
The Pfizer-BioNTech #COVID19 vaccine has not been approved or licensed by the @US_FDA but has been authorized for emergency use to prevent COVID-19 in individuals 16+. See conditions of use: https://t.co/OS1tgYopUj

[Amanda Kay @AJKay17]

Great news @synlogic_tx team!

[Synlogic @synlogic_tx]

Synlogic Announces Advancement of SYNB1891 to Combination Arm Dosing with PD-L1 Checkpoint Inhibitor in the on-going Phase 1 Study for the Treatment of Solid Tumors and Lymphoma: https://t.co/AKWnBYmtql

[Amanda Kay @AJKay17]

@synlogic_tx Wonderful news!

[Amanda Kay @AJKay17]

Deep Genomics is partnering with BioMarin to predict and develop new therapies for rare disease patients using our AI Workbench! Let’s get started!
https://t.co/eG4XXGQKpG
#AI #MachineLearning

[Amanda Kay @AJKay17]

@aoifemlbrennan @synlogic_tx Love this!

[Amanda Kay @AJKay17]

Perhaps not the news the world is waiting for today...but joining a very newsworthy company! Very excited to join this dedicated team!

[Deep Genomics @deepgenomics]

We are delighted to welcome Amanda Kay to the team!
Read more here: https://t.co/TEh6TRYmrx

[Amanda Kay @AJKay17]

Amazing story...congratulations Anna and team!

[Aoifemlbrennan @aoifemlbrennan]

Today, the @synlogic_tx team published in @naturecomms on the development of SYNB1891. I thought I would tell the story behind the paper; how we used #synbio to take something from idea to the clinic in a few years
https://t.co/RG0LZuL8Ba (1/10)

[Amanda Kay @AJKay17]

Congratulations team!

[Synlogic @synlogic_tx]

Today @NatureComms published data supporting our first immuno-oncology program - SYNB1891 is a dual innate immune activator currently being evaluated in a Phase 1 clinical trial in patients with advanced solid tumors or lymphoma. https://t.co/Qn6V4hPipE